Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Treatment of pediatric multiple sclerosis.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
Sleep loss as risk factor for neurologic disorders: A review.
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
[Vitamin D and multiple sclerosis].
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Multiple sclerosis: Monotherapy rules.
The effects of exercise training on fitness, mobility, fatigue, and health related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report.
Risk factors for idiopathic optic neuritis recurrence.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
How microglia kill neurons.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.

Pages